Linda Huguelet

Diagnosed with myeloma in 2010, Linda today co-leads the Chattanooga Multiple Myeloma Networking Group, alongside her husband. Linda will be attending the ASH Annual Meeting for the fith time. She recently participated in a CAR-T Patient Advocacy Forum hosted by Celgene and she’ll add CAR-T therapies to the things she’s most excited to learn about at the ASH conference.  Maintenance therapies, updates on the approved monoclonal antibodies, and new emerging monoclonal antibody treatments will also be a focus for her.